Efficacy and Safety of Filgotinib for Patients with Rheumatoid Arthritis Naive to Methotrexate Therapy: FINCH 3 Primary Outcome Results

被引：0
作者：
Haaland, Derek [1 ]
van der Heijde, Desiree [2 ]
Westhovens, Rene [3 ]
Rigby, William [4 ]
Ching, Daniel [5 ]
Bartok, Beatrix [6 ]
Matzkies, Franziska [6 ]
Yin, Zhaoyu [6 ]
Guo, Ying [6 ]
Paulino, Marcelo [7 ]
Tasset, Chantal [8 ]
Sundy, John [6 ]
Mozaffarian, Neelufar [6 ]
Messina, Osvaldo [9 ]
Landewe, Robert [10 ]
Atsumi, Tatsuya [11 ]
Burmester, Gerd [12 ,13 ]
机构：
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] UZ Leuven Campus Gasthuisberg, Leuven, Belgium
[4] Dartmouth Coll USA, Lebanon, NH USA
[5] Timaru Med Specialists Ltd, Timaru, New Zealand
[6] Gilead Sci USA, Foster City, CA USA
[7] Gilead Sci, Mississauga, ON, Canada
[8] Galapagos NV, Mechelen, Belgium
[9] Cosme Argerich Hosp, Buenos Aires, DF, Argentina
[10] Amsterdam Rheumatol & Clin Immunol Ctr, Amsterdam, Netherlands
[11] Hokkaido Univ, Sch Med, Sapporo, Hokkaido, Japan
[12] Charite Univ Med Berlin, Berlin, Germany
[13] Humboldt Univ, Berlin, Germany
来源：
JOURNAL OF RHEUMATOLOGY | 2020年 / 47卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
117
引用
收藏
页码：1084 / 1085
页数：2
相关论文
共 50 条
  • [31] Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial
    Westhovens, Rene
    Rigby, William F. C.
    van der Heijde, Desiree
    Ching, Daniel W. T.
    Stohl, William
    Kay, Jonathan
    Chopra, Arvind
    Bartok, Beatrix
    Matzkies, Franziska
    Yin, Zhaoyu
    Guo, Ying
    Tasset, Chantal
    Sundy, John S.
    Jahreis, Angelika
    Mozaffarian, Neelufar
    Messina, Osvaldo Daniel
    Landewe, Robert B. M.
    Atsumi, Tatsuya
    Burmester, Gerd R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (06) : 727 - 738
  • [32] Safety Profile of Methotrexate Therapy in Patients With Rheumatoid Arthritis
    Mustafa, Syed Hassan
    Ahmad, Tausif
    Balouch, Malab
    Iqbal, Farah
    Durrani, Talha
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
  • [33] Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1)
    Tanaka, Yoshiya
    Matsubara, Tsukasa
    Atsumi, Tatsuya
    Amano, Koichi
    Ishiguro, Naoki
    Sugiyama, Eiji
    Yamaoka, Kunihiro
    Combe, Bernard G.
    Kivitz, Alan J.
    Bae, Sang-Cheol
    Keystone, Edward C.
    Nash, Peter
    Matzkies, Franziska
    Bartok, Beatrix
    Pechonkina, Alena
    Kondo, Akira
    Ye, Lei
    Guo, Ying
    Tasset, Chantal
    Sundy, John S.
    Takeuchi, Tsutomu
    [J]. MODERN RHEUMATOLOGY, 2022, 32 (02) : 263 - 272
  • [34] Filgotinib Improved Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results from FINCH-1 Study
    Younossi, Zobair
    Stepanova, Maria
    Gerber, Lynn
    Lee, Susan
    Hu, Hao
    Hendrikx, Thijs
    Boonen, Annelies
    Walker, David
    Alten, Rieke
    Combe, Bernard
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [35] Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy
    Alten, R. E.
    Zerbini, C.
    Jeka, S.
    Irazoque, F.
    Khatib, F.
    Emery, P.
    Bertasso, A.
    Rabbia, M.
    Caulfield, J. P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (02) : 364 - 367
  • [36] EFFECT OF FILGOTINIB ON PAIN IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THE PHASE 3 FINCH 1, 2 AND 3 STUDIES
    Taylor, P. C.
    Kavanaugh, A.
    Nash, P.
    Pope, J.
    Pongratz, G.
    Fautrel, B.
    Alten, R.
    Hasegawa, K.
    Rao, S.
    De Vries, D.
    Stiers, P. J.
    Watson, C.
    Westhovens, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1326 - 1327
  • [37] EFFICACY AND SAFETY OF CERTOLIZUMAB PEGOL WITH METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS
    Carlino, G.
    Cozzolongo, A.
    Maggio, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 1049 - 1049
  • [38] Efficacy and safety of rituximab in rheumatoid arthritis patients refractory to methotrexate
    Moreland L.
    [J]. Current Rheumatology Reports, 2006, 8 (5) : 368 - 368
  • [39] Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial
    Emery, Paul
    Fleischmann, Roy M.
    Strusberg, Ingrid
    Durez, Patrick
    Nash, Peter
    Amante, Eric Jason B.
    Churchill, Melvin
    Park, Won
    Pons-Estel, Bernardo
    Han, Chenglong
    Gathany, Timothy A.
    Xu, Stephen
    Zhou, Yiying
    Leu, Jocelyn H.
    Hsia, Elizabeth C.
    [J]. ARTHRITIS CARE & RESEARCH, 2016, 68 (06) : 744 - 752
  • [40] SAFETY OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: ANALYSIS OF LYMPHOCYTES IN THE LONG-TERM EXTENSION FINCH 4 STUDY
    Gottenberg, J. E.
    Burmester, G. R.
    Van Beneden, K.
    Watson, C.
    Seghers, I.
    Rajendran, V.
    Dagna, L.
    Buch, M. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 512 - 513
12345